Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexlansoprazole vs lansoprazole for acute peptic ulcer upper GI bleeding
CTR20181006Phase 2Completed
- Sponsor
- Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexlansoprazole in upper gastrointestinal bleeding (UGIB), gastric ulcer, duodenal ulcer, sponsored by Jiangsu Aosaikang Pharmaceutical Co., Ltd.. Started Jul 2018; status: completed.
02
Drugs
dexlansoprazole
03
Conditions
upper gastrointestinal bleeding (UGIB)gastric ulcerduodenal ulcer
Beyond the preview
Go deeper on CTR20181006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181006.